BlueMountain Capital Management and IsZo Capital File Lawsuit Against Taro Pharmaceutical Industries Ltd. to Revoke the Results of the September 12, 2013 General Meeting

News provided by

BlueMountain Capital Management

21 Nov, 2013, 05:04 ET

NEW YORK, Nov. 21, 2013 /PRNewswire/ -- BlueMountain Capital Management, LLC ("BlueMountain") informed its fellow minority shareholders today that BlueMountain, several of its funds, and IsZo Capital LP ("IsZo Capital") filed a claim against Taro Pharmaceutical Industries Ltd. (NYSE: TARO) on November 19, 2013 in the Israeli District Court for the Central District to vacate most of the resolutions which were voted upon at the general meeting of TARO's shareholders held on September 12, 2013 (the "General Meeting"). BlueMountain and IsZo Capital are the two largest minority shareholders of TARO.

The claim was filed in light of alleged breaches of Israeli law by TARO in connection with the General Meeting. Specifically, BlueMountain and IsZo Capital have asked the court to revoke the following resolutions passed at the General Meeting: (i) the resolution reelecting the external directors of TARO (Issue 7 on the agenda of the General Meeting); (ii) the resolutions approving compensation of officers of TARO (Issues 3, 4, 5 on the agenda of the General Meeting); and (iii) the resolution approving TARO's compensation policy (Issue 1 on the agenda of the General Meeting).

As set forth in greater detail in the legal claim, the voting process and TARO's conduct prior to, during, and after the General Meeting were materially flawed.  Among other issues, voting was conducted using defective voting cards and instruction forms, in which the shareholders participating in the vote were not required to disclose the existence (or non-existence) of a personal interest in the adoption of the resolutions, as required by Israeli Law. BlueMountain alerted TARO of these fundamental flaws prior to and during the General Meeting.

BlueMountain and IsZo Capital have also asked the court to order TARO to provide BlueMountain and IsZo Capital with copies of all voting cards, voting instruction forms and details of the online votes, which were used in the General Meeting, as well as the minutes of the General Meeting.

BlueMountain believes that the filing of this claim is material to the shareholders of TARO and therefore expected that TARO would have made a public disclosure informing all shareholders of its existence. Since TARO failed to do so, BlueMountain has elected to announce this decision publicly.

Media Contacts:
Doug Hesney / Mary Kate Kim
Dukas Public Relations
212-704-7385
[email protected] / [email protected]

SOURCE BlueMountain Capital Management

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.